Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

1.99
Delayed Data
As of Sep 23
 -0.0639 / -3.12%
Today’s Change
1.26
Today|||52-Week Range
6.49
-48.01%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close2.05
Today’s open2.03
Day’s range1.97 - 2.04
Volume18,357
Average volume (3 months)54,079
Market cap$13.0M
Dividend yield--
Data as of 3:58pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+73.42%
Earnings growth (this year)+35.71%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales558.44
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
XTNTXtant Medical Holdin...-0.12-9.75%
IGCIndia Globalization ...+0.02+4.81%
MATNMateon Therapeutics ...+0.02+2.61%
BNTCBenitec Biopharma Lt...+0.06+4.50%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 10, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$34.0K
Annual profit (last year)-$10.2M
Net profit margin-30,067.65%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts

Search for Jobs